Back to Market返回行情

ACTI.ST Active Biotech AB (publ)

STOHealthcare

$5.66+9212.50%OpenMarket Cap: $14.93B

As of 2026-06-03 11:08

Valuation

P/E (TTM)

-433.01

PEG

—

P/B

318.34

P/S

0.00

EV/EBITDA

-213.69

DCF Value

—

FCF Yield

-0.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-117.8%

ROA

-59.6%

ROIC

-74.0%

Income Statement

Periods shown are fiscal year quarters (may differ from calendar year)

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q1 2026	$0.00	—	$-8.6M	$-8.4M	$-0.00	—
Q4 2025	$0.00	—	$-9.1M	$-9.1M	$-0.01	—
Q3 2025	$0.00	—	$-6.0M	$-6.0M	$-0.00	—
Q2 2025	$0.00	—	$-11.3M	$-11.2M	$-0.01	—
Q1 2025	$0.00	—	$-11.2M	$-11.0M	$-0.01	—
Q4 2024	$0.00	—	$-10.3M	$-10.2M	$-0.02	—
Q3 2024	$0.00	—	$-8.1M	$-8.0M	$-0.01	—
Q2 2024	$0.00	—	$-10.7M	$-10.6M	$-0.03	—
Q1 2024	$0.00	—	$-10.7M	$-10.5M	$-0.03	—
Q4 2023	$0.00	—	$-12.8M	$-12.5M	$-0.04	—
Q3 2023	$0.00	—	$-10.6M	$-10.6M	$-0.04	—
Q2 2023	$0.00	—	$-11.3M	$-11.2M	$-0.04	—